HIF1A and breast carcinoma: Overall, while multiple phytochemicals exhibit consistent anti-HIF-1α effects in vitro and in vivo, the absence of well-designed clinical trials directly measuring HIF-1α activity in breast cancer tumors precludes definitive conclusions regarding their therapeutic efficacy.